Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Spectinomycin in gonorrhoea.

J Ribeiro, S I Mathieson

    The British Journal of Venereal Diseases
    |August 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Spectinomycin is an effective treatment for uncomplicated gonorrhea in males, with a low failure rate of 1.1%. The antibiotic was well-tolerated, and most tested strains of Neisseria gonorrhoeae were sensitive to it.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    "Cayenne pepper" rash - A case of Schamberg disease.

    Semergen·2026
    Same author

    A bio-behavioral model of systemic inflammation at breast cancer diagnosis and fatigue of clinical importance 2 years later.

    Annals of oncology : official journal of the European Society for Medical Oncology·2024
    Same author

    Correction: Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65.

    Gene therapy·2024
    Same author

    Study protocol: a pragmatic, cluster-randomized controlled trial to evaluate the effect of implementation of the Truenat platform/MTB assays at primary health care clinics in Mozambique and Tanzania (TB-CAPT CORE).

    BMC infectious diseases·2024
    Same author

    Learning lessons from the COVID-19 pandemic for real-world evidence research in oncology-shared perspectives from international consortia.

    ESMO open·2023
    Same author

    COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases.

    ESMO open·2023
    Same journal

    (1) ANNUAL REPORT OF THE CITY AND ROYAL BURGH OF EDINBURGH V.D. SCHEME.:(2) ANNUAL REPORT ON THE V.D. SCHEME OF THE CITY OF SALFORD.

    The British journal of venereal diseases·2011
    Same journal

    THE BULLETIN OF THE JAPANESE SOCIETY OF SYPHILOGRAPHY, DERMATOLOGICAL INSTITUTE, IMPERIAL UNIVERSITY OF KYOTO, 1935, VOL. 12, NOS. 2 (APRIL) AND 3 (JUNE).

    The British journal of venereal diseases·2011
    Same journal

    Case of Chancroid of a Finger.

    The British journal of venereal diseases·2011
    Same journal

    Some Aspects of the History Of the Origin of Syphilis: Transmutation from Frambesia to Syphilis.

    The British journal of venereal diseases·2011
    Same journal

    Antenatal Anti-Syphilitic Treatment: A Hopeful Outlook.

    The British journal of venereal diseases·2011
    Same journal

    Quantitative Serum Tests in Syphilis.

    The British journal of venereal diseases·2011
    See all related articles

    Area of Science:

    • Infectious Diseases
    • Pharmacology
    • Microbiology

    Background:

    • Gonorrhea remains a significant public health concern, necessitating effective antimicrobial treatments.
    • Spectinomycin has been utilized for gonorrhea treatment, but its efficacy and tolerability require ongoing evaluation.

    Purpose of the Study:

    • To assess the efficacy and tolerability of spectinomycin in treating uncomplicated acute gonorrhea.
    • To determine the treatment failure rate in male patients receiving spectinomycin.
    • To evaluate the susceptibility of Neisseria gonorrhoeae strains to spectinomycin.

    Main Methods:

    • A clinical trial involving 104 male and 9 female patients with uncomplicated acute gonorrhea.
    • Patients were treated with spectinomycin (2 g for males, 4 g for females).

    Related Experiment Videos

  • Follow-up assessments were conducted, and antimicrobial susceptibility testing was performed on Neisseria gonorrhoeae isolates.

    • Main Results:

    • A low treatment failure rate of 1.1% was observed in male patients followed for two weeks or more.
    • The drug was generally well-tolerated by the study participants.
    • Antimicrobial susceptibility testing revealed that 42 out of 44 Neisseria gonorrhoeae strains were sensitive to 2-5 µg/ml of spectinomycin, and all strains were sensitive to 5 µg/ml.

    Conclusions:

    • Spectinomycin demonstrates high efficacy and good tolerability for treating uncomplicated gonorrhea in male patients.
    • The observed susceptibility patterns suggest spectinomycin remains a viable treatment option against Neisseria gonorrhoeae.
    • Further investigation is warranted to establish definitive conclusions for female patients due to the small sample size.